HECTD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.86388707088281E-13 |
Normal-vs-Stage2 |
1.61240000018381E-07 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.63136171238421E-12 |
Stage1-vs-Stage2 |
3.313800E-01 |
Stage1-vs-Stage3 |
4.86859999981881E-07 |
Stage1-vs-Stage4 |
4.799700E-04 |
Stage2-vs-Stage3 |
1.297040E-01 |
Stage2-vs-Stage4 |
1.999190E-01 |
Stage3-vs-Stage4 |
8.246800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
4.83420004027124E-09 |
Normal-vs-Asian |
4.454000E-02 |
Caucasian-vs-AfricanAmerican |
6.994800E-01 |
Caucasian-vs-Asian |
2.275800E-01 |
AfricanAmerican-vs-Asian |
3.482000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.68665081901054E-12 |
Male-vs-Female |
8.487600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.65579999898003E-08 |
Normal-vs-Age(41-60Yrs) |
2.15719664353742E-11 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
2.50710008309341E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.734600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.677000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.927200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.074100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.712500E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.016200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.197500E-02 |
Normal-vs-Grade 2 |
1.76070269475304E-12 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
8.470400E-02 |
Grade 1-vs-Grade 3 |
1.378450E-03 |
Grade 1-vs-Grade 4 |
2.783400E-04 |
Grade 2-vs-Grade 3 |
1.436160E-04 |
Grade 2-vs-Grade 4 |
3.80870000000755E-05 |
Grade 3-vs-Grade 4 |
1.284590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62825308791525E-12 |
Normal-vs-ccB subtype |
3.49498208151999E-12 |
ccA subtype-vs-ccB subtype |
3.892200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62658775337832E-12 |
Normal-vs-N1 |
1.03560005015879E-09 |
N0-vs-N1 |
2.956300E-02 |
|
|